J Med Microbiol NEW Faster Access
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Martin, M. V.
Right arrow Articles by Bramley, P. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Martin, M. V.
Right arrow Articles by Bramley, P. A.
Agricola
Right arrow Articles by Martin, M. V.
Right arrow Articles by Bramley, P. A.

The Journal of Medical Microbiology, Vol 14, Issue 4 457-467, Copyright © 1981 by Society for General Microbiology

JOURNAL ARTICLE

Yeast flora of the mouth and skin during and after irradiation for oral and laryngeal cancer

M. V. Martin, U. Al-Tikriti and P. A. Bramley

The quantitative and qualitative changes occurring the fungal flora of 22 patients with oral and 9 with laryngeal carcinoma were studied during and after radiation therapy. Each patient received 6000 rad of externally applied radiation in divided doses for 5 weeks. The fungal flora was isolated from the patients' oral cavity and irradiated skin sites during irradiation and 2 weeks and 4-6 months afterwards. The number and types of fungi increased in both groups of patients after the start of irradiation and persisted at high levels for at least 4-6 months after treatment. Candida albicans and C. tropicalis were the principal yeasts isolated throughout the period studied but seven other species were also identified. All the yeast isolates were sensitive in vitro to miconazole, ketoconazole, amphotericin B and nystatin. Any of these antifungal agents should be appropriate for therapy.


This article has been cited by other articles:


Home page
 Crit. Rev. Oral Biol. Med.Home page
M.A.M. Sitheeque and L.P. Samaranayake
CHRONIC HYPERPLASTIC CANDIDOSIS/CANDIDIASIS (CANDIDAL LEUKOPLAKIA)
Crit. Rev. Oral. Biol. Med., July 1, 2003; 14(4): 253 - 267.
[Abstract] [Full Text] [PDF]

Home page
 CA Cancer J ClinHome page
W. J. Kostler, M. Hejna, C. Wenzel, and C. C. Zielinski
Oral Mucositis Complicating Chemotherapy and/or Radiotherapy: Options for Prevention and Treatment
CA Cancer J Clin, September 1, 2001; 51(5): 290 - 315.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Microbiol. Rev.Home page
Y. H. Samaranayake and L. P. Samaranayake
Experimental Oral Candidiasis in Animal Models
Clin. Microbiol. Rev., April 1, 2001; 14(2): 398 - 429.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Microbiol.Home page
W. K. Leung, R. S. Dassanayake, J. Y. Y. Yau, L. J. Jin, W. C. Yam, and L. P. Samaranayake
Oral Colonization, Phenotypic, and Genotypic Profiles of Candida Species in Irradiated, Dentate, Xerostomic Nasopharyngeal Carcinoma Survivors
J. Clin. Microbiol., June 1, 2000; 38(6): 2219 - 2226.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
INT J SYST EVOL MICROBIOL J MED MICROBIOL MICROBIOLOGY J GEN VIROL ALL SGM JOURNALS
Copyright © 1981 Society for General Microbiology.